PSA-based treatment response criteria in castration-resistant prostate cancer: promises and limitations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PSA-based treatment response criteria in castration-resistant prostate cancer: promises and limitations

Published:2013-05-01 Issue:5 Volume:3 Page:375
ISSN:1920-1214
Container-title:Canadian Urological Association Journal
language:
Short-container-title:CUAJ

Author:

Emmenegger Urban,Ko Yoo-Joung

Abstract

Publisher

Canadian Urological Association Journal

Subject

Urology,Oncology

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of rechallenge with [177Lu]Lu-PSMA-I&T radioligand therapy in metastatic castration resistant prostate cancer;European Journal of Nuclear Medicine and Molecular Imaging;2024-09-03

2. Prognostic Performance of RECIP 1.0 Based on [¹⁸F]PSMA-1007 PET in Prostate Cancer Patients Treated with [¹⁷⁷Lu]Lu-PSMA I&T;Journal of Nuclear Medicine;2024-03-07

3. PSMA PET/CT for Response Assessment of 177Lu-PSMA Therapy;Seminars in Nuclear Medicine;2024-01

4. Evaluation of RECIST, PERCIST, EORTC, and MDA Criteria for Assessing Treatment Response with Ga68-PSMA PET-CT in Metastatic Prostate Cancer Patient with Biochemical Progression: a Comparative Study;Nuclear Medicine and Molecular Imaging;2018-09-26

5. Disease Progression/Clinical Outcome Model for Castration‐Resistant Prostate Cancer in Patients Treated With Eribulin;CPT: Pharmacometrics & Systems Pharmacology;2015-06-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP